Xiaoping Jin

29 papers receiving 2.4k citations

Xiaoping Jin's Hit Papers

Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial 2025 · 35 citations
350+3+6Years since publication200400600

Peers

Xiaoping Jin
Comparison fields: 5 of 92
  • Oncology 1.2k
  • Surgery 795
  • Economics and Econometrics 205
  • Statistics and Probability 85
  • Modeling and Simulation 25
Replace Anila H. Qureshi with:
Anila H. Qureshi United States
Laura Marandino Italy
Julia Bonastre France
Yabing Mai United States
Ann Christine Thastrom United States
Dina Sakaeva Russia
Jeffrey Gary Schneider United States
Christina Canil Canada
Marina Tschaika United States
Eric Scott Schaefer United States
Xiaoping Jin relative to Anila H. Qureshi United States Anila H. Qureshi's profile →
Citations per field
00.5×5×10×15×20×24.5×
Anila H. Qureshi · 1×
Citations per year

Countries citing papers authored by Xiaoping Jin

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Jin more than expected).

Fields of papers citing papers by Xiaoping Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Jin. The network helps show where Xiaoping Jin may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoping Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoping Jin Line = papers co-authored together Xiaoping Jin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
Hit paper breakdown →
2017746
2
Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Hit paper breakdown →
2016727
3 2005167
4 2016158
5 2017132
6 200782
7 201380
8 201749
9 201943
10
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
Hit paper breakdown →
202535
11 201534
12 201033
13 201031
14 201828
15 202219
16 202018
17 200516
18 201615
19 200913
20 202012

About Xiaoping Jin

Xiaoping Jin is a scholar working on Oncology, Physiology, Endocrinology, Diabetes and Metabolism, Surgery and Rheumatology, having authored 33 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Spatial and Panel Data Analysis (3 papers), Adenosine and Purinergic Signaling (3 papers), Diabetes Treatment and Management (3 papers), Lung Cancer Treatments and Mutations (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Oncology (1.2k citations), Surgery (795 citations), Economics and Econometrics (205 citations), Statistics and Probability (85 citations) and Modeling and Simulation (25 citations). Xiaoping Jin has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Ashok Kumar Gupta, Bradley P. Carlin, Sudipto Banerjee, Peter H. O’Donnell, Christophe Massard, Yong Ben, Marlon Cezar Rebelatto, John A. Blake-Haskins, Joyce M. Antal and Neil Howard Segal. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Clinical Pharmacology & Therapeutics, Endocrine Practice, Expert Opinion on Investigational Drugs and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact